I have always assumed that Replicel gets far more questions on social media about its hair loss related work versus its tendon repair and skin generation related work. Nevertheless, I do not think that the company’s CEO Lee Buckler ever addressed us hair loss sufferers directly. Until today.
Replicel RCH-01 Release Date
The main point from the video address by Mr. Buckler: the earliest possible release of the company’s RCH-01 hair loss product is in 2018. And that is predicated upon successful clinical trial results from the company’s much larger Japanese partner Shiseido.
I suspect that Mr. Buckler got tired of getting the same question over and over again about when they will release the hair loss product and finally decided to release this latest video. It seems like Replicel’s disagreement with Shiseido from last year is not hurting the two companies’ long-term collaboration.
Replicel and Mr. Buckler have been extremely busy in recent weeks. Just from the past week, you can read and listen to two new interviews from the CEO:
- Replicel CEO podcast interview with James West.
- Replicel CEO podcast interview with Dr. Brian McDonough.
And there was also a detailed favorable report about the company in Zacks Investment Research two weeks ago, along with a “brokered private placement” of common shares.